approach to patient vaginal bleeding in 2nd half of pregnancy

yahyiaalabri 4,630 views 46 slides Feb 13, 2017
Slide 1
Slide 1 of 46
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46

About This Presentation

history
examination
sign and symptoms
management


Slide Content

Vaginal bleeding in 2 nd Half of pregnancy (Ante-partum hemorrhage) Yahyia Al- Abri 90440

Objectives Antepartum hemorrhage Definition Causes Case scenario Placenta previa Placental abruption Vasa previa Uterine rupture

Definition Bleeding from or in to the genital tract, occurring from 24 + weeks of pregnancy and prior to the birth of the baby. (Royal College of Obstetricians and Gynecologists ) Uterine bleeding after 20 weeks of gestation that is unrelated to labor and delivery. (UPTODATE)

Causes Common Abruptio placentae Placenta previa Preterm labor Uncommon Uterine rupture Vasa previa Cervical lesion (cervicitis, polyp, ectropion, cervical cancer) Other:coagulopathy . Hacker and moore

Case scenario H is 30 years old lady pramigarvida at 30 week of gestation she presented to the A/E with P/V bleeding. LMP: 11/5/2016 EDD : 15/2/2017  Admission : 09/12/2016 The bleeding started 1 hour ago low in amount. She noted the bleeding while she was passing urine. She had two episodes in less than 24 hours. no abdominal pain no dysuria No fever No other complain good fetal movements

Case scenario Past medical :   GDM on Insulin (N15/8 units, R5/5 units) and Metformin 500 mg BID. No HTN No bleeding disorder Family history not remarkable Gyne Regular period every 28 days bleeding for 4 -5 days Never used of contraceptive No pap smear done Obstetric Planed pregnancy .Anomaly scan on 13/10/2016 no gross anomaly seen     Family history:  - mother diabetic

Case scenario On examination: Looks well. Vitally stable. T: 36.5 P: 88 BP: 130/80 saturation 98% Patient abdomen: soft, relaxed uterus, no tenderness. Patient cervix : no bleeding, os closed.

Placenta previa

Definition Abnormal location of placenta near , partially , or completely over the internal cervical os . Epidemiology: 0.5% of all pregnancies .

Risk factors Multiparty. Increasing maternal age. History of prior placenta previa . Multiple gestation

Placenta previa in referral hospital in oman

Classifications Placenta Previa is classified according to the relationship of the placenta to the internal cervical os .

Complete placenta previa placenta totally covers the cervical os . Central anterior Posterior depending on where the center of the placenta is located relative to the os .

Partial placenta previa placenta partially covers the internal cervical os .

Marginal placenta previa The edge of the placenta extends to the margin of the internal cervical os .

Low-lying placenta The placental margin is within 2 cm of the endocervical os .

Ultrasound classification of placenta previa Grade I: (low lying placenta) placenta lies in lower uterine segment but its lower edge does not Join the internal cervical os ( i.e lower edge 0.5-5.0 cm from internal os ). Grade II: (marginal praevia ) placental tissue reaches the margin of the internal cervical os , but does not cover it Grade III: (partial praevia ) placenta partially covers the internal cervical os Grade IV: (complete praevia ) placenta completely covers the internal cervical os

Clinical features PAINLESS bright red vaginal bleeding ( recurrent ) Shock/anemia correspond to degree of apparent blood loss. Uterus soft and non-tender Malpresentation , failure of the fetal head to engage. FHR usually normal Do NOT perform a vaginal exam until placenta previa has been ruled out by U/S

Investigations (laboratory) CBC ( hemoglobin, platelet ). Coagulation profile(INR/ aPTT ). Blood group type and Cross match. CTG ( fetal monitoring )

Radiological Ultrasound Transvaginal U/S is more accurate than transabdominal U/S at diagnosing placenta previa at any gestational age.

Placenta previa Treatment: Asymptomatic placenta previa: monitor placental position with ultrasound examination as an outpatient avoid vaginal intercourse, digital examination, avoid exercise Advise to seek immediate medical attention if contractions or vaginal bleeding occur Delivery by C-section at 37 weeks

Management Symptomatic Stabilize and monitor Maternal stabilization: large bore IV lines with hydration, O2 for hypotensive patients. M aternal monitoring: vitals, urine output, blood loss. CTG. U/S assessment: D etermine fetal viability. Placental status/position.

Management GA <37 weeks and minimal bleeding: Expectant management Admit to hospital Limited physical activity, no douches, enemas, Consider corticosteroids for fetal lung maturity Delivery when fetus is mature or hemorrhage is excessive GA ≥37 weeks, and/or bleeding is excessive: Delivery must be accomplished by C-section regardless of gestational age!

Complications * postpartum hypopituitarism caused by ischemic necrosis due to blood loss and hypovolemic shock during and after childbirth. Fetal Maternal Perinatal mortality Prematurity Maternal mortality <1% Sheehan syndrome* Placenta accreta Hysterectomy Acute renal failure

Placental Abruption

Definition Premature separation of normal implanted placenta from the uterine wall before the delivery of the fetus. Epidemiology : 0.5 % to 1.5 % of all pregnancies.

Abruptio placenta Pathophysiology: hemorrhage into the decidua basalis Decidua splits Decidual hematoma formation Separation and compression of the placenta adjacent to it destruction of placental tissue.

Perinatal mortality in Oman

Risk factors Maternal hypertension (most common factor). History of placental abruption in a prior pregnancy. Trauma. Premature rupture of membranes. Short umbilical cord. Smoking.

Partial Vs Complete

Visible Vs Concealed

Clinical features PAINFUL (80%) vaginal bleeding bleeding not always present if abruption is concealed . Pain sudden onset, constant, localized to lower back and uterus .

Clinical features O/E General condition depends on the amount of bleeding (shock/anemia out of proportion to apparent blood loss) Uterus is Hard and Tender nonreassuring FH, reduced or absent fetal movements, fetal distress

Investigations U/S not sensitive for diagnosing abruption (sensitivity = 15 %) Classical US finding is retroplacental clot.

Management S tabilization & monitoring : M aternal stabilization: large bore IV with hydration, O2 for hypotensive patients. M aternal monitoring: vitals, urine output, blood loss. CTG. Blood products on hand , because of DIC risk.

Management Mild abruption GA <37 weeks: use serial Hct to assess concealed bleeding, deliver when fetus is mature or when hemorrhage is excessive. GA ≥37 weeks: stabilize and deliver. Moderate to severe abruption Immediate delivery. Vaginal delivery if no contraindication and no evidence of fetal or maternal distress OR fetal demise. C/S if there is fetal or maternal distress.

Complications Fetal Maternal Perinatal mortality Prematurity Intrauterine hypoxia Maternal mortality DIC (in 20% of abruptions) Acute renal failure Anemia Sheehan syndrome Abruptio placentae is the most common cause of DIC in pregnancy

Vasa previa

Definition U nprotected fetal vessels pass over the cervical os ; Associated with velamentous insertion of cord into membranes of placenta.

Clinical Features PAINLESS vaginal bleeding . F etal distress.

Vasa previa Investigations Apt test ( alkai denaturation test) to determine if the source of bleeding is fetal. TVS examination with color Doppler Treatment: emergency C/S (since bleeding is from fetus, a small amount of blood loss can have catastrophic consequences)

Uterine rupture

Definition C omplete separation of the uterine musculature through all of its layers, with all or a part of the fetus being extruded from the uterine cavity. Epidemiology: 0.5% of all pregnancies. A prior uterine scar is associated with 40% of cases .

Risk factors Previous C\S (types and number). Previous uterine myomectomy. Congenital uterine anomalies. Multiparty. Fetal macrosomia. Labor induction. Uterine instrumentation\ trauma.

Clinical features highly variable. S udden onset of intense abdominal pain. V aginal bleeding . Shock (Profound maternal tachycardia and hypotension) Fetal parts may be more easily palpated abdominally.

Management I mmediate laparotomy In most cases, total abdominal hysterectomy is the treatment of choice. Debridement of the rupture site and primary closure may be considered in women of low parity who desire more children . fluid and blood transfusion